Manato Yasuda

Chiba, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Response to the comment on "Longitudinal MuSK antibody levels may correlate with disease severity in MuSK myasthenia gravis".

Response to the comment on "Longitudinal MuSK antibody levels may correlate with disease severity in MuSK myasthenia gravis".

Journal: Journal of neuroimmunology

Published: August 04, 2026

Headache prevalence and types in multiple sclerosis and related neuroimmunological diseases: A multicenter study.

Headache prevalence and types in multiple sclerosis and related neuroimmunological diseases: A multicenter study.

Journal: Cephalalgia : an international journal of headache

Published: March 26, 2026

Extrathymic malignancies in patients with myasthenia gravis: A Japanese multicenter study.

Extrathymic malignancies in patients with myasthenia gravis: A Japanese multicenter study.

Journal: Internal medicine (Tokyo, Japan)

Published: March 26, 2026

Opposing effects of efgartigimod and rozanolixizumab on serum albumin levels in patients with generalized myasthenia gravis.

Opposing effects of efgartigimod and rozanolixizumab on serum albumin levels in patients with generalized myasthenia gravis.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: February 17, 2026

Diagnosis of Lambert-Eaton myasthenic syndrome: Muscle fatigue with normal manual muscle testing, areflexia, and electrodiagnostic findings.

Diagnosis of Lambert-Eaton myasthenic syndrome: Muscle fatigue with normal manual muscle testing, areflexia, and electrodiagnostic findings.

Journal: Journal of neuroimmunology

Published: February 11, 2026

Longitudinal MuSK antibody levels may correlate with disease severity in MuSK myasthenia gravis.

Longitudinal MuSK antibody levels may correlate with disease severity in MuSK myasthenia gravis.

Journal: Journal of neuroimmunology

Published: December 03, 2025

Heterozygous HTRA1-related Cerebral Small Vessel Disease with Short Stature and Limbs.

Heterozygous HTRA1-related Cerebral Small Vessel Disease with Short Stature and Limbs.

Journal: Internal medicine (Tokyo, Japan)

Published: October 08, 2025

Association of baseline acetylcholine receptor antibody levels with efgartigimod treatment efficacy for patients with myasthenia gravis.

Association of baseline acetylcholine receptor antibody levels with efgartigimod treatment efficacy for patients with myasthenia gravis.

Journal: Journal of the neurological sciences

Published: July 27, 2025

Serum from patients with MuSK antibody-positive myasthenia gravis triggers transcriptomic changes leading to muscle atrophy and weakness in human myotube cells.

Serum from patients with MuSK antibody-positive myasthenia gravis triggers transcriptomic changes leading to muscle atrophy and weakness in human myotube cells.

Journal: Journal of neuroimmunology

Published: June 18, 2025

Serum from patients with acetylcholine receptor antibody-positive myasthenia gravis triggers pathogenic changes in human myotube cells.

Serum from patients with acetylcholine receptor antibody-positive myasthenia gravis triggers pathogenic changes in human myotube cells.

Journal: Journal of neuroimmunology

Published: June 13, 2025

Association between Myasthenia Gravis and Smoking.

Association between Myasthenia Gravis and Smoking.

Journal: Internal medicine (Tokyo, Japan)

Published: June 11, 2025

Corticosteroid-induced Cushingoid Appearance in Myasthenia Gravis.

Corticosteroid-induced Cushingoid Appearance in Myasthenia Gravis.

Journal: Internal medicine (Tokyo, Japan)

Published: June 04, 2025

Showing 1-12 of 53

Last Updated: 09/26/2026